Showing results (521-530 of 572) with videos related to

Sort By:
Pageof 58
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2024
Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical OutcomesSophie C H Wen, Patrick N A Harris, Brian Forde, et al.
International Journal of Antimicrobial Agents|January 18, 2025
Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort studyAbdullah Tarık Aslan, Emre Kara, Gamze Köksal, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive BacteriaDavid M P De Oliveira, Bernhard Keller, Andrew J Hayes, et al.
The Lancet. Microbe|May 11, 2022
Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological studyCong Shen, Lan-Lan Zhong, Yongqiang Yang, et al.
BMJ Open|December 8, 2025
Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCENick Daneman, Jennie Johnstone, Todd C Lee, et al.
Vaccine|August 4, 2011
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control studyAllen C Cheng, Tom Kotsimbos, Heath A Kelly, et al.
The New England Journal of Medicine|October 10, 2009
Critical care services and 2009 H1N1 influenza in Australia and New Zealand, Steven A R Webb, Ville Pettilä, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Global dissemination of a multidrug resistant Escherichia coli cloneNicola K Petty, Nouri L Ben Zakour, Mitchell Stanton-Cook, et al.
JAMA|June 12, 2024
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical TrialJoel M Dulhunty, Stephen J Brett, Jan J De Waele, et al.
Trials|February 11, 2025
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Pageof 58